Status:
COMPLETED
Specific Oral Tolerance Induction to Cow's Milk Allergy
Lead Sponsor:
General University Hospital of Valencia
Conditions:
Food Hypersensitivity
Eligibility:
All Genders
24-36 years
Phase:
NA
Brief Summary
Background: Limited published evidence shows specific oral tolerance induction (SOTI) to be a potential intervention option for cow's milk proteins (CMPs) allergy. Our hypothesis is that SOTI should b...
Eligibility Criteria
Inclusion
- -Infants between 24-36 months of age.
- -IgE-mediated allergy to CMPs meeting all the following diagnostic criteria:
- Immediate-type clinical manifestations, skin (urticaria, angioedema and/or erythema), digestive (acute vomiting and/or diarrhea) or respiratory (bronchospasm and/or rhinitis) involvement in the first two hours after cow's milk ingestion.
- Skin test readings ≥ 3 mm and specific IgE titers \> 0.35 kU/l for whole cow's milk or someone of isolated CMPs (casein, alpha-lactalbumin, beta-lactoglobulin )
- -Persistence of CMP allergy in the four weeks prior to tolerance induction, based on the following criteria:
- Skin (prick) test readings ≥3 mm and specific IgE titers (CAP-FEIA) \>0.35 kU/l for whole cow's milk or someone of isolated CMPs (casein, alpha-lactalbumin, beta-lactoglobulin )
- Double-blind placebo-controlled challenge (DBPCFC) positive to cow's milk.
- -Written informed consent from the parents.
Exclusion
- -Clinical manifestations of anaphylactic shock after the ingestion of cow's milk.
- -Non-IgE-mediated or non-immunological adverse reactions to cow's milk.
- -Malignant or immunopathological diseases and/or severe primary or secondary immune deficiencies.
- -Patients receiving immunosuppressor therapy.
- -Patients receiving beta-blockers (including topical formulations).
- -Associated diseases contraindicating the use of adrenalin: cardiovascular disease or severe hypertension
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01199484
Last Update
September 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergy Unit. University General Hospital
Valencia, Valencia, Spain, 46014